Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors

The single photon emission computed tomography (SPECT) radiotracer [123I]iomazenil is used to assess benzodiazepine receptor binding parameters. These measurements are relative indices of benzodiazepine receptor concentration (B′max). To evaluate the ability of such indices in accurately accessing the B′max the authors compared them with absolute values of B′max, measured using positron emission tomography (PET). The authors performed SPECT, PET, and magnetic resonance imaging (MRI) studies on a group composed of seven subjects. For SPECT studies, the authors administered a single injection of [123I]iomazenil and estimated the total and specific distribution volumes (DVT SPECT, DVS SPECT) and the binding potential (BP) using unconstrained (BPSPECT) and constrained (BPC SPECT) compartmental models. For PET studies, the authors used a multiinjection approach with [11C]flumazenil and unlabeled flumazenil to estimate absolute values of receptor concentration, B′max, and some other binding parameters. The authors studied the correlation of different binding parameters with B′max. To study the robustness of the binding parameter measurements at the pixel level, the authors applied a wavelet-based filter to improve signal-to-noise ratio of time-concentration curves, and the calculated kinetic parameters were used to build up parametric images. For PET data, the B′max and the DVPET were highly correlated (r = 0.988). This confirms that it is possible to use the DVPET to access benzodiazepine receptor density. For SPECT data, the correlation between DVSPECT estimated using a two-and three-compartment model was also high (r = 0.999). The DVT SPECT and BPC SPECT parameters estimated with a constrained three-compartment model or the DVT″SPECT parameter estimated with a two-compartment model were also highly correlated to the B′max parameter estimated with PET. Finally, the robustness of the binding parameters allowed the authors to build pixel-by-pixel parametric images using SPECT data.

[1]  C Crouzel,et al.  Quantification of Benzodiazepine Receptors in Human Brain Using PET, [11C]Flumazenil, and a Single-Experiment Protocol , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Keiichi Oda,et al.  Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF , 1999, Annals of nuclear medicine.

[3]  L Cinotti,et al.  Parameter and index images of benzodiazepine receptor concentration in the brain. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J. Seibyl,et al.  SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Z Rattner,et al.  Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  J. Mazziotta,et al.  Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.

[7]  J. Baron,et al.  Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  J. Baron,et al.  Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.

[9]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[10]  E. Sybirska,et al.  Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[11]  J. Baron,et al.  A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[12]  J Delforge,et al.  Concept of reaction volume in the in vivo ligand-receptor model. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[14]  G A Clarke,et al.  Clinical experience with a multidetector SPET system (Toshiba GCA‐9300A) , 1994, Nuclear medicine communications.

[15]  P B Hoffer,et al.  Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil. , 1993, European journal of pharmacology.

[16]  S. Mallat A wavelet tour of signal processing , 1998 .

[17]  W. Haefely,et al.  Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies , 1985, Nature.

[18]  N L Foster,et al.  Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. , 1995, Archives of neurology.

[19]  W. Haefely Biochemistry of anxiety. , 1985, Annals of the Academy of Medicine, Singapore.

[20]  G A Clarke,et al.  Physical performance evaluation of the Toshiba GCA-9300A triple-headed system. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  W. Haefely Pharmacology of Benzodiazepine Antagonists , 1985, Pharmacopsychiatry.

[22]  R. Koeppe,et al.  Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.

[23]  O. Muzik,et al.  Altered In Vitro and In Vivo Flumazenil Binding in Human Epileptogenic Neocortex , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  P B Hoffer,et al.  Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  D E Kuhl,et al.  Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  Christer Halldin,et al.  Saturation analysis of specific 11C Ro 15‐1788 binding to the human neocortex using positron emission tomography , 1989 .

[27]  C Burger,et al.  Modeling alternatives for cerebral carbon-11-iomazenil kinetics. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  A. Syrota,et al.  Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. , 1984, Life sciences.

[29]  M. Kuhar,et al.  Benzodiazepine receptor binding in vivo with [3H]-Ro 15-1788. , 1985, Life sciences.

[30]  Bernard Bendriem,et al.  Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium Approaches , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  R H Huesman,et al.  Dynamic PET Data Analysis , 1986, Journal of computer assisted tomography.

[32]  J. S. Duncan,et al.  Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Robert B. Innis,et al.  SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  José Guimón,et al.  Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor Concentration , 2000, NeuroImage.

[35]  Robert B. Innis,et al.  SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: I. Kinetic Modeling of Single Bolus Experiments , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[37]  L H Staib,et al.  Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [11C]Iomazenil in healthy human subjects , 2000, Synapse.